Vitiligo onset following anti-inflammatory biological therapy: a scoping review
IntroductionVitiligo is a chronic autoimmune depigmentation skin disorder characterized by the acquired loss of melanocytes, with a complex multifactorial pathophysiology. Among the potential predisposing factors, some drugs, including monoclonal antib…